Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Toth

Showing results (281-290 of 335) with videos related to

Pageof 34
Sort By:
Bioorganic & Medicinal Chemistry|October 19, 2006
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolaseIn-Hae Kim, Kosuke Nishi, Hsing-Ju Tsai, et al.
Nanomedicine (London, England)|November 11, 2016
Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide deliveryNirmal Marasini, Ashwini K Giddam, Zeinab G Khalil, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2015
Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumorsPeter M Moyle, Wei Dai, Tzu-Yu Liu, et al.
Nanomedicine (London, England)|December 23, 2014
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicityMehfuz Zaman, Saranya Chandrudu, Ashwini K Giddam, et al.
Acta Biomaterialia|September 30, 2018
Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcusReshma J Nevagi, Zeinab G Khalil, Waleed M Hussein, et al.
Journal of Medicinal Chemistry|December 13, 2007
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidatesAbu-Baker M Abdel-Aal, Michael R Batzloff, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry|June 2, 2016
Structure-activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidatesAmy Chan, Waleed M Hussein, Khairunnisa Abdul Ghaffar, et al.
Journal of Medicinal Chemistry|February 19, 2008
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccinesPavla Simerska, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry|April 7, 2016
Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluationFazren Azmi, Alysha G Elliott, Nirmal Marasini, et al.
Mbio|October 19, 2021
Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage MalariaDanielle I Stanisic, Mei-Fong Ho, Reshma Nevagi, et al.
Pageof 34

Showing results (281-290 of 335) with videos related to

Sort By:
Pageof 34
Bioorganic & Medicinal Chemistry|October 19, 2006
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolaseIn-Hae Kim, Kosuke Nishi, Hsing-Ju Tsai, et al.
Nanomedicine (London, England)|November 11, 2016
Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide deliveryNirmal Marasini, Ashwini K Giddam, Zeinab G Khalil, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2015
Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumorsPeter M Moyle, Wei Dai, Tzu-Yu Liu, et al.
Nanomedicine (London, England)|December 23, 2014
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicityMehfuz Zaman, Saranya Chandrudu, Ashwini K Giddam, et al.
Acta Biomaterialia|September 30, 2018
Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcusReshma J Nevagi, Zeinab G Khalil, Waleed M Hussein, et al.
Journal of Medicinal Chemistry|December 13, 2007
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidatesAbu-Baker M Abdel-Aal, Michael R Batzloff, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry|June 2, 2016
Structure-activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidatesAmy Chan, Waleed M Hussein, Khairunnisa Abdul Ghaffar, et al.
Journal of Medicinal Chemistry|February 19, 2008
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccinesPavla Simerska, Abu-Baker M Abdel-Aal, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry|April 7, 2016
Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluationFazren Azmi, Alysha G Elliott, Nirmal Marasini, et al.
Mbio|October 19, 2021
Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage MalariaDanielle I Stanisic, Mei-Fong Ho, Reshma Nevagi, et al.
Pageof 34